ClinicalTrials.Veeva

Menu

Evaluation of a New CZT System

T

Tel Aviv Sourasky Medical Center

Status

Unknown

Conditions

Thyroid Adenoma
Parathyroid Adenoma

Study type

Observational

Funder types

Other

Identifiers

NCT01084356
TASMC-10-EES-0649-CTIL

Details and patient eligibility

About

The purpose of the study is to check if the new CZT system has an advantage in detection of small osseous processes, thyroid adenomas, parathyroid adenomas and detection of sentinel node, in comparison with the techniques in use.

Participants: 100 subjects male and female that come to the institute of nuclear medicine for routine screening examinations.

The CZT screening takes 10 minutes and does not require any extra intervention to the routine screening.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age over 18

Exclusion criteria

  • pregnancy
  • patients unable to understand and sign an informed consent
  • age under 18

Trial design

100 participants in 4 patient groups

hand
Description:
patients admitted for Tc MDP for evaluation of carpal/metacarpal and finger bone lesions
thyroid
Description:
patients admitted for Tc thyroid scan
parathyroid
Description:
patients investigated for parathyroid adenoma
sentinel node
Description:
patients who are due to sentinel node biopsy

Trial contacts and locations

1

Loading...

Central trial contact

Einat Even Sapir, PhD,MD; Ayelet Kurzband, BA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems